Skip to main content

Labcyte Taps Tekon Biotech for China Distribution

NEW YORK (GenomeWeb news) – Labcyte said today that Tekon Biotech will serve as exclusive distributor for its low-volume liquid transfer systems in China, Hong Kong, and Taiwan.

Sunnyvale, Calif.-based Labcyte's Echo liquid handlers, which use sound to move liquid, are marketed to pharmaceutical companies and academic and research institutions for use in genomics, proteomics, particle manufacturing, encapsulation, imaging mass spectrometry, and live-cell transfer.

"As we expand in Asia, Tekon will help us broaden our existing user base in the pharmaceutical industry and the contract research organizations that service them," Labcyte's Senior VP of Sales, Marketing, and Service, Stephen Bates, said in a statement.

"We see a great potential market for low-volume transfer devices in China," Tekon CEO David Hadfield said, citing "growing genomics markets, especially for gene expression, SNP analysis, and RNAi."

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.